Product and variants
Retatrutide
20 mg · 30 mg
Retatrutide batch WMRT20260717
Variant-linked analytical facts transcribed from the original COA PDF files. This page applies only to the batch and variants named below.
Reported 27 Jul 2026 · Received 21 Jul 2026 · Record updated 14 Aug 2026
Reported purity
99.67% · RP-HPLC (220 nm)
Reported identity
ESI-MS · Conforms
Original source documents
Each link below is kept beside the exact variant named in the source record.
20 mgRetatrutide · WMRT20260717Purity 99.67% · RP-HPLC (220 nm) · Identity ESI-MSOpen original COA PDF
30 mgRetatrutide · WMRT20260717Purity 99.67% · RP-HPLC (220 nm) · Identity ESI-MSOpen original COA PDF
Interpretation boundary
Chromatographic purity and mass-spectrometry identity answer different analytical questions. These results do not alone establish sterility, endotoxin status, fill quantity, stability, protocol suitability, or safety for human or animal use.
Source status
Published PDFs are supplier or manufacturer documentation. They are not presented as independent or accredited laboratory reports unless the PDF itself identifies the testing laboratory and accreditation.
Record history
— Initial human-readable record created from the linked source PDF. Material corrections will be dated here.